[#item_full_content] The Connecticut Senate has passed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the full Senate in a unanimous 35-0 vote on Wednesday. It now heads to the House of Representatives. 
Read More
Connecticut Senate Votes To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval
ByPot Shop News
April 9, 2026